Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BI 44847 in healthy Japanese male subjects
NCT02211924Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Aug 2007
- Primary completion
- Sep 2007
01
Overview
Phase 1, randomised, double-blind trial of BI-44847 in type 2 diabetes mellitus (T2DM), sponsored by Boehringer Ingelheim. Primary endpoint: Number of patients with clinically relevant changes in vital signs at 7 days. Started Aug 2007; status: completed.
02
Drugs
BI-44847
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02211924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02211924.